15.03.23|CTechThe Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches
05.01.22|James SpiroThe company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level